TR200001122T2 - Biphenyl derivatives as pharmaceuticals. - Google Patents
Biphenyl derivatives as pharmaceuticals.Info
- Publication number
- TR200001122T2 TR200001122T2 TR2000/01122T TR200001122T TR200001122T2 TR 200001122 T2 TR200001122 T2 TR 200001122T2 TR 2000/01122 T TR2000/01122 T TR 2000/01122T TR 200001122 T TR200001122 T TR 200001122T TR 200001122 T2 TR200001122 T2 TR 200001122T2
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceuticals
- biphenyl derivatives
- biphenyl
- derivatives
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Abstract
Içerisinde R1, R2, R3, R4, ve R5'in,tarifnamede tanimlandigi gibi oldugu formül (I)'deki bilesikler, farmasötikler olarak faydalidirlar.Compounds of formula (I) in which R1, R2, R3, R4, and R5 are as defined herein are useful as pharmaceuticals.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9723133.6A GB9723133D0 (en) | 1997-11-03 | 1997-11-03 | Organic compounds |
| GBGB9723134.4A GB9723134D0 (en) | 1997-11-03 | 1997-11-03 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200001122T2 true TR200001122T2 (en) | 2000-08-21 |
Family
ID=26312535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/01122T TR200001122T2 (en) | 1997-11-03 | 1998-10-30 | Biphenyl derivatives as pharmaceuticals. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1037876A1 (en) |
| JP (1) | JP2001521923A (en) |
| KR (1) | KR20010031699A (en) |
| CN (1) | CN1278249A (en) |
| AR (1) | AR016148A1 (en) |
| AU (1) | AU740448B2 (en) |
| BR (1) | BR9813897A (en) |
| CA (1) | CA2308151A1 (en) |
| CO (1) | CO5011067A1 (en) |
| ID (1) | ID24413A (en) |
| IL (1) | IL135580A0 (en) |
| NO (1) | NO20002321D0 (en) |
| NZ (1) | NZ503815A (en) |
| PE (1) | PE123599A1 (en) |
| PL (1) | PL339922A1 (en) |
| SK (1) | SK6412000A3 (en) |
| TR (1) | TR200001122T2 (en) |
| WO (1) | WO1999023073A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6858592B2 (en) | 2001-06-29 | 2005-02-22 | Genzyme Corporation | Aryl boronic acids for treating obesity |
| US7041280B2 (en) | 2001-06-29 | 2006-05-09 | Genzyme Corporation | Aryl boronate functionalized polymers for treating obesity |
| TW200840566A (en) * | 2006-12-22 | 2008-10-16 | Esteve Labor Dr | Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments |
| US8642583B2 (en) | 2008-10-30 | 2014-02-04 | Janssen Pharmaceutica Nv | Serotonin receptor modulators |
| US8575364B2 (en) * | 2008-10-30 | 2013-11-05 | Janssen Pharmaceutica Nv | Modulators of serotonin receptor |
| DE102009015697A1 (en) | 2009-03-31 | 2010-10-07 | Markus Dr. Heinrich | Process for the arylation of ring-substituted phenols and phenyl ethers |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2114122A (en) * | 1938-04-12 | Alcohols and process fob making | ||
| DE674968C (en) * | 1935-01-15 | 1939-04-26 | Roehm & Haas Company | Process for the preparation of phenolic aralkylamino alcohols |
| US2040039A (en) * | 1935-02-26 | 1936-05-05 | Rohm & Haas | Phenolic morpholines |
| US2485550A (en) * | 1946-06-25 | 1949-10-25 | Hoffmann La Roche | Quaternary salts of carbamic acid esters of tertiary-hydroxybenzyl-amines |
| US2493710A (en) * | 1947-03-21 | 1950-01-03 | Hoffmann La Roche | Carbamic acid esters |
| US2872477A (en) * | 1957-04-05 | 1959-02-03 | Dow Chemical Co | alpha-(dialkylamino)-6-phenyl-o-cresol esters |
| JPS5328150A (en) * | 1976-08-25 | 1978-03-16 | Sugai Chemical Ind Co Ltd | Novel orthophenyl phenol derivative process for preparing same |
| KR900012875A (en) * | 1989-02-08 | 1990-09-03 | 오스카 아끼히꼬 | A biphenyl derivative, a neuronal cell-denatured restoration or protection agent, and a method for producing a cuneyl derivative used therein |
| US5428037A (en) * | 1993-04-09 | 1995-06-27 | Syntex Pharmaceuticals, Ltd. | Heterocyclic derivatives in the treatment of Ischaemia and related diseases |
| JPH072655A (en) * | 1993-06-18 | 1995-01-06 | Otsuka Pharmaceut Co Ltd | Agent for repairing or protecting denaturation of peripheral nerve |
| EP1123933A1 (en) * | 1994-10-14 | 2001-08-16 | MERCK PATENT GmbH | 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane as CNS active agent |
| EP0793662A1 (en) * | 1994-11-23 | 1997-09-10 | Neurogen Corporation | Aminomethyl aryl compounds; dopamine receptor subtype selective ligands |
| IL116249A (en) * | 1994-12-12 | 2003-07-06 | Pfizer | Nk-1 receptor antagonists for the treatment of neuronal damage and stroke |
| DE19637237A1 (en) * | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazine derivatives |
-
1998
- 1998-10-29 CO CO98063635A patent/CO5011067A1/en unknown
- 1998-10-30 PL PL98339922A patent/PL339922A1/en unknown
- 1998-10-30 BR BR9813897-9A patent/BR9813897A/en not_active IP Right Cessation
- 1998-10-30 AU AU14872/99A patent/AU740448B2/en not_active Ceased
- 1998-10-30 CA CA002308151A patent/CA2308151A1/en not_active Abandoned
- 1998-10-30 NZ NZ503815A patent/NZ503815A/en unknown
- 1998-10-30 TR TR2000/01122T patent/TR200001122T2/en unknown
- 1998-10-30 CN CN98810761A patent/CN1278249A/en active Pending
- 1998-10-30 JP JP2000518948A patent/JP2001521923A/en active Pending
- 1998-10-30 SK SK641-2000A patent/SK6412000A3/en unknown
- 1998-10-30 KR KR1020007004762A patent/KR20010031699A/en not_active Ceased
- 1998-10-30 ID IDW20000790A patent/ID24413A/en unknown
- 1998-10-30 IL IL13558098A patent/IL135580A0/en unknown
- 1998-10-30 AR ARP980105469A patent/AR016148A1/en not_active Application Discontinuation
- 1998-10-30 WO PCT/EP1998/006880 patent/WO1999023073A1/en not_active Ceased
- 1998-10-30 EP EP98958884A patent/EP1037876A1/en not_active Withdrawn
- 1998-11-02 PE PE1998001034A patent/PE123599A1/en not_active Application Discontinuation
-
2000
- 2000-05-02 NO NO20002321A patent/NO20002321D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20002321L (en) | 2000-05-02 |
| PL339922A1 (en) | 2001-01-15 |
| IL135580A0 (en) | 2001-05-20 |
| JP2001521923A (en) | 2001-11-13 |
| NZ503815A (en) | 2002-05-31 |
| CA2308151A1 (en) | 1999-05-14 |
| CO5011067A1 (en) | 2001-02-28 |
| CN1278249A (en) | 2000-12-27 |
| ID24413A (en) | 2000-07-20 |
| EP1037876A1 (en) | 2000-09-27 |
| NO20002321D0 (en) | 2000-05-02 |
| KR20010031699A (en) | 2001-04-16 |
| AU1487299A (en) | 1999-05-24 |
| WO1999023073A1 (en) | 1999-05-14 |
| PE123599A1 (en) | 1999-12-20 |
| AR016148A1 (en) | 2001-06-20 |
| SK6412000A3 (en) | 2000-09-12 |
| BR9813897A (en) | 2000-09-26 |
| AU740448B2 (en) | 2001-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199901653T2 (en) | Phthalazinones. | |
| ATE269312T1 (en) | N-(AMIDINOPHENYL)-N'-(NOUN)-3H-2,4-BENZODIAZEPINE-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS | |
| PT931788E (en) | METALOPROTEASE INHIBITORS | |
| YU11997A (en) | Lactamic derivatives and pharmaceutical compositions thereof | |
| TR199901473T2 (en) | Ha�ere �ld�r�c� 1-arilpirazoller | |
| MXPA03008754A (en) | Pyridine derivatives. | |
| DK1200418T3 (en) | Nematodicidal trifluorobutene | |
| NZ233735A (en) | Heterocyclic substituted aminophenol derivatives | |
| SE9702773D0 (en) | Novel compounds | |
| TR199900856T2 (en) | Benzonaphthyridines as bronchial therapy agents | |
| IL140070A0 (en) | Benzamide derivatives and pharmaceutical compositions containing the same | |
| TR200201128T2 (en) | Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors. | |
| TR200001909T2 (en) | Matrix metalloprosthesis inhibitors. | |
| ATE320422T1 (en) | METALLOPROTEINASE INHIBITORS | |
| DE60202669D1 (en) | 6-PHENYLBENZONAPHTHYIDINE | |
| TR199701298T1 (en) | Tetralins. | |
| TR200001122T2 (en) | Biphenyl derivatives as pharmaceuticals. | |
| IT1293777B1 (en) | PROCESS FOR THE PREPARATION OF TETRAAZAMACROCYCLES | |
| DE59803066D1 (en) | SUBSTITUTED BENZYLOXYIMINO COMPOUNDS | |
| PT1104419E (en) | AZABICYCLOHEPTAN DERIVATIVES SUBSTITUTED IN NITROGEN ITS PREPARATION AND UTILIZATION | |
| ATE247649T1 (en) | DISUBSTITUTED BIPHENYLOXAZOLINES | |
| DK0713485T3 (en) | Thiocarbamoyl compounds as microbicides | |
| PT1140932E (en) | 1,8-BENZONETHYRIDINE DERIVATIVES | |
| ID27964A (en) | TURUNA-AZABISIKLOHEPTANA N-SUBSTITUTED, MAKING AND USING IT | |
| ES2151820A1 (en) | Herbicides |